These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18593009)

  • 1. Approaching therapies for boys with Duchenne muscular dystrophy. Parent Project Muscular Dystrophy. Annual conference in Cincinnati/Ohio, 13-16 July 2006.
    Scheuerbrandt G
    Acta Myol; 2006 Oct; 25(2):77-97. PubMed ID: 18593009
    [No Abstract]   [Full Text] [Related]  

  • 2. Duchenne and Becker muscular dystrophies.
    Flanigan KM
    Neurol Clin; 2014 Aug; 32(3):671-88, viii. PubMed ID: 25037084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duchenne muscular dystrophy.
    Biggar WD
    Pediatr Rev; 2006 Mar; 27(3):83-8. PubMed ID: 16510548
    [No Abstract]   [Full Text] [Related]  

  • 4. The Action Duchenne 13th International Annual Conference, November 6-7, 2015, London, UK.
    Ribeiro D; Stuckey DW
    EBioMedicine; 2015 Dec; 2(12):1836-7. PubMed ID: 26844248
    [No Abstract]   [Full Text] [Related]  

  • 5. Report on a Round Table Conference in Monaco on 17th and 18th January, 2004.
    Scheuerbrandt G
    Acta Myol; 2004 Sep; 23(2):106-22. PubMed ID: 15605953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking under every rock: Duchenne muscular dystrophy and traditional Chinese medicine.
    Urtizberea JA; Fan QS; Vroom E; Récan D; Kaplan JC
    Neuromuscul Disord; 2003 Nov; 13(9):705-7. PubMed ID: 14561492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Duchenne muscular dystrophy (DMD) for the pediatricians in the community.
    Verma S; Anziska Y; Cracco J
    Clin Pediatr (Phila); 2010 Nov; 49(11):1011-7. PubMed ID: 20724320
    [No Abstract]   [Full Text] [Related]  

  • 8. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscular dystrophy.
    Roland EH
    Pediatr Rev; 2000 Jul; 21(7):233-7; quiz 238. PubMed ID: 10878185
    [No Abstract]   [Full Text] [Related]  

  • 10. Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy.
    Davidson ZE; Ryan MM; Kornberg AJ; Walker KZ; Truby H
    J Child Neurol; 2015 Mar; 30(3):357-63. PubMed ID: 24762862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontline studies on Duchenne muscular dystrophy treatment].
    Matsuo M
    No To Hattatsu; 2009 Mar; 41(2):92-5. PubMed ID: 19517771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on Duchenne muscular dystrophy].
    Leiva-Cepas F; Montaño Martínez A; López-López I
    Semergen; 2021 Oct; 47(7):472-481. PubMed ID: 34417099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the management of the child with Duchenne muscular dystrophy in a resource poor setting:a case report.
    Odinaka KK; Nwolisa EC
    Pan Afr Med J; 2014; 19():227. PubMed ID: 25838855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys.
    Heutinck L; Kampen NV; Jansen M; Groot IJ
    J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exon skipping therapy for Duchenne muscular dystrophy: outcome of preclinical study and prospective for clinical study].
    Nakamura A; Takeda S
    No To Hattatsu; 2010 Mar; 42(2):117-23. PubMed ID: 23858595
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a symptomatic Duchenne muscular dystrophy carrier 20 years after myoblast transplantation from her asymptomatic identical twin sister.
    Hogrel JY; Zagnoli F; Canal A; Fraysse B; Bouchard JP; Skuk D; Fardeau M; Tremblay JP
    Neuromuscul Disord; 2013 Jul; 23(7):575-9. PubMed ID: 23731976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy.
    Straub V; Balabanov P; Bushby K; Ensini M; Goemans N; De Luca A; Pereda A; Hemmings R; Campion G; Kaye E; Arechavala-Gomeza V; Goyenvalle A; Niks E; Veldhuizen O; Furlong P; Stoyanova-Beninska V; Wood MJ; Johnson A; Mercuri E; Muntoni F; Sepodes B; Haas M; Vroom E; Aartsma-Rus A
    Lancet Neurol; 2016 Jul; 15(8):882-890. PubMed ID: 27302365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for duchenne muscular dystrophy: expectations and challenges.
    Rodino-Klapac LR; Chicoine LG; Kaspar BK; Mendell JR
    Arch Neurol; 2007 Sep; 64(9):1236-41. PubMed ID: 17846262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimplantation genetic diagnosis associated to Duchenne muscular dystrophy.
    Bianco B; Christofolini DM; Conceição GS; Barbosa CP
    Einstein (Sao Paulo); 2017; 15(4):489-491. PubMed ID: 28954035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.